Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ADVM Adverum Biotechnologies

Watchlist
0.641
-0.019-2.88%
Close  12/06 16:00 ET
0.6410.0000.00%
Post Mkt Price 12/06 16:06 ET
High
0.670
Open
0.654
Turnover
117.51K
Low
0.639
Pre Close
0.660
Volume
181.03K
Market Cap
63.91M
P/E(TTM)
Loss
52wk High
2.040
Shares
99.73M
P/E(Static)
Loss
52wk Low
0.630
Float Cap
54.71M
Bid/Ask %
14.29%
Historical High
62.480
Shs Float
85.37M
Volume Ratio
0.42
Historical Low
0.630
Dividend TTM
--
Div Yield TTM
--
P/B
0.31
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.21%
Amplitude
4.70%
Avg Price
0.649
Lot Size
1
Float Cap
54.71M
Bid/Ask %
14.29%
Historical High
62.480
Shs Float
85.37M
Volume Ratio
0.42
Historical Low
0.630
Dividend TTM
--
P/B
0.31
Dividend LFY
--
Turnover Ratio
0.21%
Amplitude
4.70%
Avg Price
0.649
Lot Size
1
Price Forecast

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
CEO: Dr. Laurent Fischer, M.D.
Market: NASDAQ
Listing Date: 07/31/2014
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist